Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$2.07 - $2.89 $117,426 - $163,943
-56,728 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$2.34 - $3.44 $24,460 - $35,958
10,453 Added 22.59%
56,728 $148,000
Q4 2020

Jan 29, 2021

BUY
$1.91 - $5.63 $88,385 - $260,528
46,275 New
46,275 $129,000

Others Institutions Holding SIOX

About Sio Gene Therapies Inc.


  • Ticker SIOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,975,200
  • Description
  • Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...
More about SIOX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.